SCM
PRAX icon

Sterling Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Sterling Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.5K Sell
88
-716
-89% -$227K ﹤0.01% 1721
2026
Q1 		$259K Sell
804
-407
-34% -$126K ﹤0.01% 1061
2025
Q4 		$357K Buy
1,211
+65
+6% +$12.1K 0.01% 1113
2025
Q3 		$60.7K Buy
1,146
+701
+158% +$34K ﹤0.01% 1698
2025
Q2 		$18.7K Buy
445
+427
+2,372% +$16.3K ﹤0.01% 1819
2025
Q1 		$682 Hold
18
– – ﹤0.01% 2911
2024
Q4 		$1.39K Hold
18
– – ﹤0.01% 2873
2024
Q3 		$1.04K Buy
+18
New +$972 ﹤0.01% 2505

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Sterling Capital Management's PRAX Position: Q2 2026 in Review

Sterling Capital Management reduced its Praxis Precision Medicines (PRAX) stake by 89% in Q2 2026, selling an estimated $227K and leaving 88 shares worth $29.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1721.

Sterling Capital Management first reported a position in PRAX in Q3 2024 and has held it in 8 quarters since. The position peaked at $357K in Q4 2025. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Sterling Capital Management held 88 shares of Praxis Precision Medicines worth $29.5K as of Q2 2026.
  • Sterling Capital Management sold 716 Praxis Precision Medicines shares in Q2 2026, an estimated $227K.
  • Praxis Precision Medicines made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1721 holding.
  • Sterling Capital Management first reported a position in Praxis Precision Medicines in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Praxis Precision Medicines position peaked at $357K in Q4 2025.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.